Package 50242-078-55

Brand: susvimo

Generic: ranibizumab
NDC Package

Package Facts

Identity

Package NDC 50242-078-55
Digits Only 5024207855
Product NDC 50242-078
Description

1 VIAL in 1 CARTON (50242-078-55) / 1 mL in 1 VIAL

Marketing

Marketing Status
Discontinued 2027-09-30
Brand susvimo
Generic ranibizumab
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVITREAL"], "spl_id": "2850382e-4e4f-4005-a047-33fc758bafef", "openfda": {"nui": ["N0000193542", "N0000193543"], "unii": ["ZL1R02VT79"], "rxcui": ["2584857", "2584863"], "spl_set_id": ["9c6d9e2a-9a77-4d11-b692-de87cfde3444"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "pharm_class_moa": ["Vascular Endothelial Growth Factor Inhibitors [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (50242-078-12)  / 1 mL in 1 VIAL", "package_ndc": "50242-078-12", "marketing_start_date": "20211022"}, {"sample": false, "description": "1 VIAL in 1 CARTON (50242-078-55)  / 1 mL in 1 VIAL", "package_ndc": "50242-078-55", "marketing_end_date": "20270930", "marketing_start_date": "20211022"}], "brand_name": "Susvimo", "product_id": "50242-078_2850382e-4e4f-4005-a047-33fc758bafef", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Vascular Endothelial Growth Factor Inhibitor [EPC]", "Vascular Endothelial Growth Factor Inhibitors [MoA]"], "product_ndc": "50242-078", "generic_name": "Ranibizumab", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Susvimo", "active_ingredients": [{"name": "RANIBIZUMAB", "strength": "100 mg/mL"}], "application_number": "BLA761197", "marketing_category": "BLA", "marketing_start_date": "20211022", "listing_expiration_date": "20261231"}